The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Abstract
The cardiometabolic syndrome (CMS), with its increased risk for cardiovascular disease (CVD), nonalcoholic fatty liver disease (NAFLD), and chronic kidney disease (CKD), has become a growing worldwide health problem. Insulin resistance is a key factor for the development of the CMS and is strongly related to obesity, hyperlipidemia, hypertension, type 2 diabetes mellitus (T2DM), CKD, and NAFLD. Insulin resistance in skeletal muscle is particularly important since it is normally responsible for more than 75% of all insulin-mediated glucose disposal. However, the molecular mechanisms responsible for skeletal muscle insulin resistance remain poorly defined. Accumulating evidence indicates that low-grade chronic inflammation and oxidative stress play fundamental roles in the development of insulin resistance, and inflammatory cytokines likely contribute to the link between inflammation, oxidative stress, and skeletal muscle insulin resistance. Understanding the mechanisms by which skeletal muscle tissue develops resistance to insulin will provide attractive targets for interventions, which may ultimately curb this serious problem. This review is focused on the effects of inflammatory cytokines and oxidative stress on insulin signaling in skeletal muscle and consequent development of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
THIS ARTICLE HAS BEEN RETRACTED Exercise induces interleukin‐8 expression in human skeletal muscle
Akerstrom, T. C. A., Steensberg, A., Keller, P., Keller, C., Penkowa, M., & Pedersen, B. K. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.077610 · Cited by 131
RetractedPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“1) There is an extensive association of oxidative stress with obesity and diabetes (24, 90).”
BackgroundInflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“IL-10 is also overexpressed in adipose tissue macrophages from lean mice, which protect adipocytes from TNF- -induced insulin resistance (45).”
BackgroundInflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“ROS induce JNK activation which, in turn, may result in insulin resistance (28, 35, 38).”
BackgroundKanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 1×
“2) Treatment with hydrogen peroxide in insulinsensitive cell lines, such as 3T3–1 adipocytes and L6 myocytes induces insulin resistance, while the addition of antioxidants, such as -lipoic acid and apocynin to the cells abrogates this effect (32, 46, 70, 71, 84, 95).”
BackgroundLocal and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“IL-6 has inhibitory effects on the gene transcription of IRS-1, GLUT-4, and peroxisome proliferator-activated receptor- under these conditions (14, 68).”
BackgroundProtection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Cooperation of Toll-like receptor signals in innate immune defence
Trinchieri, G., & Sher, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2038 · Cited by 1,364
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304 · cited 1×
“, NF- B and AP-1), and upregulate expression of proinflammatory genes such as TNF- , IL-6, MCP-1, and CRP (11, 26, 54, 55), which are involved in the pathogenesis of inflammation, obesity, and insulin resistance (92, 98).”
BackgroundAdvances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Pedersen, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00237.x · Cited by 1,095 · cited 1×
“IL-6 is produced by various cell types, including skeletal muscle (1, 25, 44, 61).”
BackgroundReactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Taniyama, Y., & Griendling, K. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000100443.09293.4f · Cited by 1,066
Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
The Role of Interleukin-1 in Disease
Epstein, F. H., Dinarello, C. A., & Wolff, S. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280207 · Cited by 954
Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601284200 · Cited by 917
Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E., et al. (2006) · Diabetes · doi:10.2337/db05-1404 · Cited by 898 · cited 1×
“IL-6 may exert an insulin-sensitizing effect and enhance insulin-stimulated glucose disposal in muscle (16, 59, 69).”
BackgroundRole of Myokines in Exercise and Metabolism
Pedersen, B. K., Åkerström, T. C. A., Nielsen, A. R., & Fischer, C. P. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00080.2007 · Cited by 841
Hotamisligil, G. S., Budavari, A., Murray, D., & Spiegelman, B. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117495 · Cited by 819
The expression of TNF alpha by human muscle. Relationship to insulin resistance.
Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., & Kern, P. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118504 · Cited by 717
Mori, H., Hanada, R., Hanada, T., Aki, D., Mashima, R., Nishinakamura, H., Torisu, T., Chien, K. R., Yasukawa, H., & Yoshimura, A. (2004) · Nature Medicine · doi:10.1038/nm1071 · Cited by 651
Plomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627
Muscle‐derived interleukin‐6: possible biological effects
Pedersen, B. K., Steensberg, A., & Schjerling, P. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0329c.xd · Cited by 599 · cited 3×
“Studies have shown that exercise releases large quantities of IL-6 from muscle, suggesting that IL-6 may play a crucial role in maintaining glucose homeostasis during and after exercise (44, 61).”
BackgroundVascular inflammation and the renin-angiotensin system
Brasier, A. R., Recinos, A., & Eledrisi, M. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021412.56621.a2 · Cited by 586 · cited 3×
“ROS activate transcription factors (e.g., NF-B and AP-1), and upregulate expression of proinflammatory genes such as TNF-␣, IL-6, MCP-1, and CRP (11, 26, 54, 55), which are involved in the pathogenesis of inflammation , obesity, and insulin resistance (92, 98).”
BackgroundThe role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Perreault, M., & Marette, A. (2001) · Nature Medicine · doi:10.1038/nm1001-1138 · Cited by 539
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534
Cytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M. (1986) · Science · doi:10.1126/science.3086977 · Cited by 529
Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
Rudich, A., Tirosh, A., Potashnik, R., Hemi, R., Kanety, H., & Bashan, N. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1562 · Cited by 483 · cited 1×
“2) Treatment with hydrogen peroxide in insulinsensitive cell lines, such as 3T3–1 adipocytes and L6 myocytes induces insulin resistance, while the addition of antioxidants, such as -lipoic acid and apocynin to the cells abrogates this effect (32, 46, 70, 71, 84, 95).”
BackgroundSpecificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling
Nathan, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18174 · Cited by 456
Physical activity and modulation of systemic low-level inflammation
Bruunsgaard, H. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0505247 · Cited by 429
de Alvaro, C., Teruel, T., Hernandez, R., & Lorenzo, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312021200 · Cited by 428
Steinberg, G. R., Michell, B. J., van Denderen, B. J. W., Watt, M. J., Carey, A. L., Fam, B. C., Andrikopoulos, S., Proietto, J., Görgün, C. Z., Carling, D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.005 · Cited by 417
Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men
Urakawa, H., Katsuki, A., Sumida, Y., Gabazza, E. C., Murashima, S., Morioka, K., Maruyama, N., Kitagawa, N., Tanaka, T., Hori, Y., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030202 · Cited by 416
Maddux, B. A., See, W., Lawrence, J. C., Goldfine, A. L., Goldfine, I. D., & Evans, J. L. (2001) · Diabetes · doi:10.2337/diabetes.50.2.404 · Cited by 405
NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats
Muller, D. N., Dechend, R., Mervaala, E. M. A., Park, J.-K., Schmidt, F., Fiebeler, A., Theuer, J., Breu, V., Ganten, D., Haller, H., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.193 · Cited by 405
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
The Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1
Dinarello, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431011 · Cited by 373
Glucose Induces β-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets
Maedler, K., Spinas, G. A., Lehmann, R., Sergeev, P., Weber, M., Fontana, A., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1683 · Cited by 367
The metabolic syndrome: role of skeletal muscle metabolism.
Stump, C. S., Henriksen, E. J., Wei, Y., & Sowers, J. R. (2006) · Annals of Medicine · doi:10.1080/07853890600888413 · Cited by 362
Self-citationThe anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control
Pedersen, B. K. (2006) · Essays in Biochemistry · doi:10.1042/bse0420105 · Cited by 349
Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide
Kaneto, H., Nakatani, Y., Miyatsuka, T., Kawamori, D., Matsuoka, T.-A., Matsuhisa, M., Kajimoto, Y., Ichijo, H., Yamasaki, Y., & Hori, M. (2004) · Nature Medicine · doi:10.1038/nm1111 · Cited by 337
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., & Sowers, J. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00522.2007 · Cited by 317
Self-citationRelationships between plasma measures of oxidative stress and metabolic control in NIDDM
Nourooz-Zadeh, J., Rahimi, A., Tajaddini-Sarmadi, J., Tritschler, H., Rosen, P., Halliwell, B., & Betteridge, D. J. (1997) · Diabetologia · doi:10.1007/s001250050729 · Cited by 303
Tirosh, A., Potashnik, R., Bashan, N., & Rudich, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10595 · Cited by 301
Angiotensin II-induced NADPH Oxidase Activation Impairs Insulin Signaling in Skeletal Muscle Cells
Wei, Y., Sowers, J. R., Nistala, R., Gong, H., Uptergrove, G. M.-E., Clark, S. E., Morris, E. M., Szary, N., Manrique, C., & Stump, C. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601320200 · Cited by 297
Self-citationIshiki, M., & Klip, A. (2005) · Endocrinology · doi:10.1210/en.2005-0850 · Cited by 281
Interleukin-15: a novel anabolic cytokine for skeletal muscle
Quinn, L. S. (1995) · Endocrinology · doi:10.1210/en.136.8.3669 · Cited by 278
CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK
Watt, M. J., Dzamko, N., Thomas, W. G., Rose-John, S., Ernst, M., Carling, D., Kemp, B. E., Febbraio, M. A., & Steinberg, G. R. (2006) · Nature Medicine · doi:10.1038/nm1383 · Cited by 276
Leptin modulates β cell expression of IL-1 receptor antagonist and release of IL-1β in human islets
Maedler, K., Sergeev, P., Ehses, J. A., Mathe, Z., Bosco, D., Berney, T., Dayer, J.-M., Reinecke, M., Halban, P. A., & Donath, M. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305683101 · Cited by 249
TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12muscle cells
del Aguila, L. F., Claffey, K. P., & Kirwan, J. P. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.5.e849 · Cited by 235
Sell, H., Dietze-Schroeder, D., Kaiser, U., & Eckel, J. (2006) · Endocrinology · doi:10.1210/en.2005-0969 · Cited by 225
Shiuchi, T., Iwai, M., Li, H.-S., Wu, L., Min, L.-J., Li, J.-M., Okumura, M., Cui, T.-X., & Horiuchi, M. (2004) · Hypertension · doi:10.1161/01.hyp.0000125142.41703.64 · Cited by 223
Lang, C. H., Silvis, C., Deshpande, N., Nystrom, G., & Frost, R. A. (2003) · Shock · doi:10.1097/01.shk.0000055237.25446.80 · Cited by 218
Rieusset, J., Bouzakri, K., Chevillotte, E., Ricard, N., Jacquet, D., Bastard, J.-P., Laville, M., & Vidal, H. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2232 · Cited by 200 · cited 3×
“Although IL-6 induces SOCS3 production, SOCS-3 expression in human skeletal muscle in vivo is not related to insulin resistance in the presence of elevated IL-6 concentrations (67).”
BackgroundQUINN, L., STRAITBODEY, L., ANDERSON, B., ARGILES, J., & HAVEL, P. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2005.02.005 · Cited by 199 · cited 2×
“IL-15, plays a role in body weight control and insulin sensitivity (15, 65).”
BackgroundWei, Y., Sowers, J. R., Clark, S. E., Li, W., Ferrario, C. M., & Stump, C. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00456.2007 · Cited by 197 · cited 1×
“, ANG II increases ROS generation and subsequently mediates ANG II-induced increases of NF- B activation and TNF- expression in the soleus muscles from insulin-resistant transgenic (mRen2)27(Ren2) rats and the L6 myotubes treated with ANG II, consequently contributing to impaired insulin-stimulated Akt activation, GLU…”
BackgroundSelf-citationArgilés, J. M., López-Soriano, J., Almendro, V., Busquets, S., & López-Soriano, F. J. (2005) · Medicinal Research Reviews · doi:10.1002/med.20010 · Cited by 194
Interleukin-6 Regulation of AMP-Activated Protein Kinase
Ruderman, N. B., Keller, C., Richard, A.-M., Saha, A. K., Luo, Z., Xiang, X., Giralt, M., Ritov, V. B., Menshikova, E. V., Kelley, D. E., et al. (2006) · Diabetes · doi:10.2337/db06-s007 · Cited by 187
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
Pedersen, B. K., & Febbraio, M. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01208.2006 · Cited by 177
Carbó, N., López-Soriano, J., Costelli, P., Alvarez, B., Busquets, S., Baccino, F. M., Quinn, L. S., López-Soriano, F. J., & Argilés, J. M. (2001) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00188-4 · Cited by 174 · cited 1×
“IL-15, plays a role in body weight control and insulin sensitivity (15, 65).”
BackgroundBlendea, M. C., Jacobs, D., Stump, C. S., McFarlane, S. I., Ogrin, C., Bahtyiar, G., Stas, S., Kumar, P., Sha, Q., Ferrario, C. M., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00402.2004 · Cited by 171
Self-citationMaedler, K., Størling, J., Sturis, J., Zuellig, R. A., Spinas, G. A., Arkhammar, P. O. G., Mandrup-Poulsen, T. R., & Donath, M. Y. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1706 · Cited by 167
Rudich, A., Tirosh, A., Potashnik, R., Khamaisi, M., & Bashan, N. (1999) · Diabetologia · doi:10.1007/s001250051253 · Cited by 167
Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients
Torres, S., De Sanctis, J., de Briceno, L. M., Hernandez, N., & Finol, H. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810419 · Cited by 163
Bouzakri, K., & Zierath, J. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608602200 · Cited by 159
Weigert, C., Hennige, A. M., Lehmann, R., Brodbeck, K., Baumgärtner, F., Schaüble, M., Häring, H. U., & Schleicher, E. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509782200 · Cited by 158
Steensberg, A., Fischer, C. P., Sacchetti, M., Keller, C., Osada, T., Schjerling, P., van Hall, G., Febbraio, M. A., & Pedersen, B. K. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.032938 · Cited by 152
Steensberg, A., Fischer, C. P., Sacchetti, M., Keller, C., Osada, T., Schjerling, P., van Hall, G., Febbraio, M. A., & Pedersen, B. K. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00631.x · Cited by 147
Henriksen, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.002 · Cited by 136
Steinberg, G. R., McAinch, A. J., Chen, M. B., O’Brien, P. E., Dixon, J. B., Cameron‐Smith, D., & Kemp, B. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0638 · Cited by 126
Series of Monographs on Venous Thromboembolic Disease
Jaff, M. R., & Halperin, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000122867.89751.59 · Cited by 126
Somm, E., Cettour-Rose, P., Asensio, C., Charollais, A., Klein, M., Theander-Carrillo, C., Juge-Aubry, C. E., Dayer, J. M., Nicklin, M. J. H., Meda, P., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0046-x · Cited by 111
Boyd, J. H., Divangahi, M., Yahiaoui, L., Gvozdic, D., Qureshi, S. T., & Petrof, B. J. (2006) · Infection and Immunity · doi:10.1128/iai.00286-06 · Cited by 109
Angiotensin II induces insulin resistance independent of changes in interstitial insulin
Richey, J. M., Ader, M., Moore, D., & Bergman, R. N. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e920 · Cited by 103
Lappas, M., Yee, K., Permezel, M., & Rice, G. E. (2004) · Endocrinology · doi:10.1210/en.2004-0809 · Cited by 102
Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes
Frost, R. A., Nystrom, G. J., & Lang, C. H. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00490.2005 · Cited by 102
Togashi, N., Ura, N., Higashiura, K., Murakami, H., & Shimamoto, K. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018110-00011 · Cited by 101
den Boer, M. A. M., Voshol, P. J., der Elst, J. P. S.-V., Korsheninnikova, E., Ouwens, D. M., Kuipers, F., Havekes, L. M., & Romijn, J. A. (2006) · Endocrinology · doi:10.1210/en.2006-0417 · Cited by 95
Cytokines and endotoxin induce cytokine receptors in skeletal muscle
Zhang, Y., Pilon, G., Marette, A., & Baracos, V. E. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e196 · Cited by 93
Busquets, S., Figueras, M., Almendro, V., López-Soriano, F. J., & Argilés, J. M. A. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.001 · Cited by 92
Mooney, R. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01208a.2006 · Cited by 84
The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function
Neumann, D., Kollewe, C., Martin, M. U., & Boraschi, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3350 · Cited by 77
Bhatt, B. A., Dubé, J. J., Dedousis, N., Reider, J. A., & O'Doherty, R. M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00097.2005 · Cited by 69
Effect of TNF-α–Converting Enzyme Inhibitor on Insulin Resistance in Fructose-Fed Rats
Togashi, N., Ura, N., Higashiura, K., Murakami, H., & Shimamoto, K. (2002) · Hypertension · doi:10.1161/hy0202.103290 · Cited by 67
Socs1 Deficiency Enhances Hepatic Insulin Signaling
Jamieson, E. L., Chong, M. M. W., Steinberg, G. R., Jovanovska, V., Fam, B. C., Bullen, D. V. R., Chen, Y., Kemp, B. E., Proietto, J., Kay, T. W. H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502163200 · Cited by 52
Fat fuels insulin resistance through Toll-like receptors
Tschöp, M. H., & Thomas, G. (2006) · Nature Medicine · doi:10.1038/nm1206-1359 · Cited by 48
Interleukin-6 and interleukin-10 are expressed in organs of normal young and old mice.
Hacham, M., White, R. M., Argov, S., Segal, S., & Apte, R. N. (2004) · PubMed · Cited by 46
Borst, S. E., Lee, Y., Conover, C. F., Shek, E. W., & Bagby, G. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00054.2004 · Cited by 46
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
Spangenburg, E. E. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01353.2006 · Cited by 45
López‐Soriano, J., Chiellini, C., Maffei, M., Grimaldi, P. A., & Argilés, J. M. A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0012 · Cited by 44
Is Type 2 Diabetes an Autoimmune-Inflammatory Disorder of the Innate Immune System?
Kohn, L. D., Wallace, B., Schwartz, F., & McCall, K. D. (2005) · Endocrinology · doi:10.1210/en.2005-0920 · Cited by 30
Secondo, A., Pannaccione, A., Cataldi, M., Sirabella, R., Formisano, L., Renzo, G. D., & Annunziato, L. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00231.2005 · Cited by 25
Senn, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.a109.513304 · Cited by 8 · cited 14×
“It was recently shown that TLR2 is essential for the development of palmitate-induced insulin resistance in C 2 C 12 myotubes via inhibition of tyrosine phosphorylation of the insulin receptor and the phosphorylation of Akt (74).”
BackgroundInfluential
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Oxidative stress and metabolic syndrome
Roberts, C. K., & Sindhu, K. K. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.02.026 · Cited by 866
Skeletal muscle inflammation and insulin resistance in obesity
Wu, H., & Ballantyne, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88880 · Cited by 695
Rehman, K., & Akash, M. S. H. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0303-y · Cited by 671
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
Metadata
- Authors
- Wei, Y., Chen, K., Whaley-Connell, A. T., Stump, C. S., Ibdah, J. A., & Sowers, J. R.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2008-03
- Volume
- 294
- Issue
- 3
- Pages
- R673-R680
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W1968755349
- Cited by
- 258
- References
- 103
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.